KEY HIGHLIGHTS Sector REITs S-REITs monthly update (Apr 25). Results Digital Core REIT (DCREIT SP/BUY/US$0.50/Target: US$0.90) 1Q25: Tech giants continue to invest in data centres and AI. Far East Hospitality Trust (FEHT SP/BUY/S$0.545/Target: S$0.71) 1Q25: Defensive strength from mid-tier positioning and low leverage. Sheng Siong Group (SSG SP/BUY/S$1.76/Target: S$1.97) 1Q25: Expanding footprint to fuel growth. Update Wilmar International (WIL SP/BUY/S$3.06/Target: S$3.4...
Wilmar’s management updates are largely in line with our expectations. Sustained sales volume growth, on top of better crush margins yoy are expected to anchor 2025 earnings growth. Upside to CPO and sugar prices may be capped in the near term, although palm processing margins may start to improve on the flipside. That said, its legal matters in Indonesia may take a little more time to be resolved. Maintain BUY on Wilmar with an unchanged target price of S$3.45.
GREATER CHINA Results China Construction Bank (939 HK/HOLD/HK$6.79/Target: HK$7.00): 1Q25: Earnings miss due to weaker NIM and fee income; tariff risk is limited. Downgrade to HOLD. China Longyuan Power (916 HK/HOLD/HK$6.10/Target: HK$6.60): 1Q25: In line; cautious outlook amid rising curtailment rates and upcoming policy shift. China Merchants Bank (3968 HK/BUY/HK$44.50/Target: HK$49.00): 1Q25: Earnings down 2.1% yoy on weaker trading gains. Estun Automation (002747 CH/SELL/Rmb19.17/Target: Rmb...
Wilmar’s 1Q25 results are deemed in line with expectations. Core earnings improved 4% yoy with operating performance largely tracking management’s recent guidance, including recovering profit contributions by its China subsidiary. Management will host its post-1Q25 analyst briefing on 30 April. Maintain BUY on Wilmar with an unchanged target price of S$3.45.
KEY HIGHLIGHTS Results Wilmar International (WIL SP/BUY/S$3.02/Target: S$3.45) 1Q25: Results meet expectations, with core earnings up 4% yoy on stronger contribution by Food Products and Plantations & Sugar Milling segments. Maintain BUY. Update Frasers Centrepoint Trust (FCT SP/BUY/S$2.26/Target: S$2.73) Heartbeat of the heartland. Marco Polo Marine (MPM SP/BUY/S$0.042/Target:S$0.072) Ushering in a new chapter. TRADERS' CORNER Raffles Medical Group (RFMD SP): Trading BUY ...
A director at Wilmar International Limited bought 130,000 shares at 3.036SGD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
GREATER CHINA Strategy China And Hong Kong Property & Hong Kong Landlord Tariffs curtail US rate cuts, thereby hindering the recovery of Hong Kong property and tourism; Maintain OVERWEIGHT on China property. INDONESIA Strategy Alpha Picks: Outperform In Mar 25 Remove BBNI, BBRI, ASII, JSMR and KLBF; add BBCA, ICBP, ERAA and BUKA. MALAYSIA Update Pekat Group (PEKAT MK/BUY/RM1.08/Target: RM1.45) Good earnings visibility over 2025...
The selloff driven by the US’ unprecedented and perplexing tariff plans has liberated many investors of profits this year. Given the fluidity of market conditions, we highlight a number of domestic-focused stocks such as CENT, CD, DFI, HLA, PANU, PROP, RFMD, SSG and SIE as well as Singapore-focused REITS such as CDLHT, FEHT, FCT, KREIT, LREIT and PREIT. In addition, the MAS’ equity market review should inject much needed liquidity in 2H25. We lower our STI target to 3,720 (previously 4,115).
During the UOB Kay Hian Palm Oil Seminar 2025 held yesterday, our speakers forecast palm oil production in Malaysia to remain stagnant in 2025 but expect Indonesia’s output to rise. Our speakers also flagged falling palm oil exports demand amid widened price premiums vs rival vegoils, and foresee inventories building up followed by price corrections later this year. Maintain OVERWEIGHT on Indonesia and Singapore planters, and MARKET WEIGHT on Malaysian planters. Top picks: Hap Seng Plantations a...
REGIONAL Sector Plantation Guest speakers at our Palm Oil Seminar 2025 flag diverging palm production prospects between Malaysia and Indonesia, alongside downside risks to CPO prices. GREATER CHINA Results Trip.com (9961 HK/BUY/HK$462.00/Target: HK$630.00) 4Q24: Earnings beat; continuous efforts in international expansion. INDONESIA Small/Mid Cap Highlights Bumi Resources Minerals (BRMS IJ...
KEY HIGHLIGHTS Strategy Small Mid Cap: Identifying stocks that could benefit from MAS’ S$5b liquidity boost. Results Seatrium (STM SP/BUY/S$2.38/Target: S$2.96): 2024: After seven long years, STM is back in the black. Maintain BUY with a slightly higher target price of S$2.96. SATS (SATS SP/BUY/S$3.30/Target: S$3.86): 3QFY25: A slight miss; expect some uncertainties for cargo in FY26. Singapore Airlines (SIA SP/HOLD/S$6.55/Target: S$6.09): 3QFY25: Results in line; pax yield moderation to conti...
GREATER CHINA Update Shenzhen Mindray Bio-Medical Electronics (300760 CH/BUY/Rmb257.82/Target: Rmb330.00) Embraces business opportunities provided by digital and intelligent solutions. INDONESIA Update Dayamitra Telekomunikasi (MTEL IJ/BUY/Rp640/Target: Rp820) Expanding fibre optic network length by 20% following the acquisition. Maintain BUY. MALAYSIA Results MISC (MISC MK/BUY/RM7.15/Target: RM8.60) 2024: Results outperform, but marke...
The key trends discussed in the briefing generally align with our expectations. We anticipate Wilmar’s core net profit improving in 2025, driven by sales volume growth from increased market share and better soybean crush margins. The surprise is that contributions from China may be higher due to better-than-expected volume growth. We believe the market has already priced in weakness from 2024. Upgrade to BUY with a higher target price of S$3.45.
GREATER CHINA Sector Automobile: Weekly: PV sales rebound wow but remain low due to wait-and-see sentiment. Maintain MARKET WEIGHT on the sector. Top BUYs: Geely, CATL, Fuyao and Desay. Renewable Energy: Solar energy equipment: Policy-driven installation rush to support prices; milder module shipment growth in 2025. Results Alibaba Group (9988 HK/BUY/HK$120.90/Target: HK$150.00): 3QFY25: CMR beat; all-in AI; capex in next three years to exceed that of the past decade. Lenovo Group (992 HK/BUY/HK...
Wilmar’s 2H24 results are in line with our but below consensus expectations. Sales volume growth was seen across all divisions with the exception of sugar milling, while there was also lower sugar merchandising activities. While we expect earnings improvement for 2025 on better refining margins, share price may be subdued due to the ongoing case involving the 2021-22 palm oil fraud allegations in Indonesia. Total DPS declared was 6% lower at S$0.16. Maintain HOLD with a target price of S$3.18.
KEY HIGHLIGHTS Results Prime US REIT (PRIME SP/BUY/US$0.159/Target: US$0.29) 2H24: Higher portfolio valuation and recapitalisation lead to lower gearing. Genting Singapore (GENS SP/BUY/S$0.775/Target: S$1.12) 4Q24: Strong set of results within our expectations. 2025 outlook highly attractive with lush dividend yield of 5%. Maintain BUY and target price of S$1.12. Wilmar International (WIL SP/HOLD/S$3.21/Target: S$3.18) 2024: Results within expectations. Sales volum...
KEY HIGHLIGHTS Results Lendlease Global Commercial REIT (LREIT SP/BUY/S$0.53/Target: S$0.72) 1HFY25: Resilient contributions from Singapore; upside from office block at Jem. Singapore Exchange (SGX SP/HOLD/S$12.71/Target: S$12.58) 1HFY25: Record-high earnings driven by all business segments. Update Wilmar International (WIL SP/HOLD/S$3.26/Target: S$3.18) 4Q24 results preview: Better performance qoq, but lower yoy on lacklustre China operations and delayed sugar harvest. TRADERS' CORNER Seatr...
GREATER CHINA Strategy Small-Mid Cap Monthly: Countdown to Plover Bay’s 2024 results: Eyeing final dividend and 2025 outlook. Sector Automobile: Weekly: OEMs post upbeat January sales. Maintain MARKET WEIGHT. Top BUYs: Geely, CATL, Fuyao and Desay. Update Aier Eye Hospital Group (300015 CH/HOLD/Rmb12.71/Target: Rmb13.80): Expecting slower growth amid weaker demand, yet outperforming peers. Downgrade to HOLD. INDONESIA Results XL Axiata (EXCL IJ/BUY/Rp2,290/Target: Rp3,300): 4Q24: NPAT jumps 93%...
Wilmar will be releasing its 2H24 results on 20 Feb 25 after trading hours. We estimate 4Q24 core net profit at US$330m-340m and full-year core net profit at US$1.14b-1.15b, which is 3-4% lower than our forecast and 9-10% lower than consensus expectation. We expect AWL to become a subsidiary from FY26, as the agreement condition has been fulfilled. Maintain HOLD with a higher target price of S$3.18 (previously S$3.00) on a modest consumer sentiment outlook in China.
Summary Davos Life Science Pte Ltd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Davos Life Science Pte Ltd (Davos Life Science), a subsidiary of KLK OLEO, is a producer of natural botanical ingredients. The company produces palm based Tocotrienol in various consistencies...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.